Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.2950
-0.0133 (-4.31%)
At close: May 13, 2025, 4:00 PM
0.3001
+0.0051 (1.73%)
Pre-market: May 14, 2025, 8:40 AM EDT
Passage Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 63.36 | 37.57 | 21.71 | 34.6 | 128.97 | 135 | Upgrade
|
| Short-Term Investments | - | 39.18 | 92.59 | 155.01 | 186.81 | 169.82 | Upgrade
|
| Cash & Short-Term Investments | 63.36 | 76.76 | 114.29 | 189.61 | 315.77 | 304.82 | Upgrade
|
| Cash Growth | -39.39% | -32.84% | -39.72% | -39.95% | 3.59% | 91.86% | Upgrade
|
| Prepaid Expenses | 2.12 | 0.84 | 0.92 | 0.93 | 1.73 | 1.41 | Upgrade
|
| Other Current Assets | 1.19 | 1.22 | 2.74 | 6.51 | 7.57 | 10.96 | Upgrade
|
| Total Current Assets | 66.67 | 78.82 | 117.96 | 197.04 | 325.07 | 317.18 | Upgrade
|
| Property, Plant & Equipment | 19.06 | 23.13 | 32.15 | 42.24 | 23.81 | 2.8 | Upgrade
|
| Other Long-Term Assets | 0.27 | 0.46 | 0.43 | 4.27 | 6.2 | 8.03 | Upgrade
|
| Total Assets | 86.01 | 102.41 | 150.55 | 243.55 | 355.08 | 328.01 | Upgrade
|
| Accounts Payable | 1.46 | 0.74 | 1.3 | 4.07 | 9.45 | 5.27 | Upgrade
|
| Accrued Expenses | 3.99 | 6.71 | 9.67 | 10.93 | 19.39 | 15.37 | Upgrade
|
| Current Portion of Leases | 3.64 | 3.69 | 3.37 | 3.28 | - | - | Upgrade
|
| Other Current Liabilities | 8.73 | 8.23 | 2 | 0.09 | 0.66 | 0.54 | Upgrade
|
| Total Current Liabilities | 17.83 | 19.36 | 16.34 | 18.35 | 29.5 | 21.18 | Upgrade
|
| Long-Term Leases | 21.48 | 21.79 | 22.92 | 23.83 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 6.92 | 2.12 | Upgrade
|
| Total Liabilities | 39.3 | 41.15 | 39.26 | 42.18 | 36.42 | 23.29 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 721.34 | 720.48 | 705.79 | 694.73 | 675.35 | 475.62 | Upgrade
|
| Retained Earnings | -674.64 | -659.24 | -594.47 | -492.41 | -356.28 | -170.9 | Upgrade
|
| Comprehensive Income & Other | - | 0.01 | -0.04 | -0.97 | -0.41 | -0.01 | Upgrade
|
| Total Common Equity | 46.71 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | Upgrade
|
| Shareholders' Equity | 46.71 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | Upgrade
|
| Total Liabilities & Equity | 86.01 | 102.41 | 150.55 | 243.55 | 355.08 | 328.01 | Upgrade
|
| Total Debt | 25.12 | 25.48 | 26.29 | 27.11 | - | - | Upgrade
|
| Net Cash (Debt) | 38.24 | 51.28 | 88 | 162.5 | 315.77 | 304.82 | Upgrade
|
| Net Cash Growth | -51.00% | -41.73% | -45.85% | -48.54% | 3.59% | 91.86% | Upgrade
|
| Net Cash Per Share | 0.62 | 0.85 | 1.61 | 2.99 | 5.92 | 7.89 | Upgrade
|
| Filing Date Shares Outstanding | 62.15 | 62.15 | 55.6 | 54.62 | 54.29 | 53.83 | Upgrade
|
| Total Common Shares Outstanding | 62.15 | 62.06 | 54.94 | 54.61 | 54.24 | 45.61 | Upgrade
|
| Working Capital | 48.84 | 59.45 | 101.62 | 178.69 | 295.57 | 296.01 | Upgrade
|
| Book Value Per Share | 0.75 | 0.99 | 2.03 | 3.69 | 5.87 | 6.68 | Upgrade
|
| Tangible Book Value | 46.71 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | Upgrade
|
| Tangible Book Value Per Share | 0.75 | 0.99 | 2.03 | 3.69 | 5.87 | 6.68 | Upgrade
|
| Machinery | - | 11.67 | 11.68 | 12.87 | 12.05 | 0.78 | Upgrade
|
| Construction In Progress | - | - | 0.64 | 1.29 | 0.82 | 1.31 | Upgrade
|
| Leasehold Improvements | - | 7.39 | 10.21 | 13.51 | 13.41 | 1.64 | Upgrade
|
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.